731: Company sponsored indrect comparison concludes the companys product is better for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage
b'Show notes at pharmacyjoe.com/episode731. In this episode, I ll discuss a company-sponsored indirect comparative study looking at andexanet alfa vs 4 factor prothrombin complex concentrate (4FPCC) for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage.'